Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.14% | -12.06% | -15.35% | -22.35% | -23.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.42% | -21.55% | -19.51% | -20.80% | -18.88% |
| Operating Income | 19.72% | 21.75% | 19.51% | 20.80% | 18.88% |
| Income Before Tax | -3.51% | 21.52% | 18.48% | 19.59% | 17.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.51% | 21.52% | 18.48% | 19.59% | 17.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.51% | 21.52% | 18.48% | 19.59% | 17.49% |
| EBIT | 19.72% | 21.75% | 19.51% | 20.80% | 18.88% |
| EBITDA | 19.70% | 22.26% | 21.01% | 22.48% | 20.51% |
| EPS Basic | 45.08% | 59.42% | 52.32% | 45.42% | 37.59% |
| Normalized Basic EPS | 55.52% | 59.42% | 52.31% | 45.41% | 37.59% |
| EPS Diluted | 45.08% | 59.42% | 52.32% | 45.42% | 37.59% |
| Normalized Diluted EPS | 55.52% | 59.42% | 52.31% | 45.41% | 37.59% |
| Average Basic Shares Outstanding | 73.58% | 95.05% | 80.12% | 59.78% | 41.47% |
| Average Diluted Shares Outstanding | 73.58% | 95.05% | 80.12% | 59.78% | 41.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |